Trial intelligence / Profile preview

Prospective evaluation of three hormonal contraceptives and cardiovascular risk markers in young women

2008-005891-28Phase 4Completed

Sponsor
AOU Policlinico di Modena
Start
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of ethinyl estradiol + desogestrel and ethinyl estradiol + drospirenone in contraception (3 arms), sponsored by AOU Policlinico di Modena. Primary endpoint: Insulin sensitivity. Started Sep 2008; status: completed.

02

Drugs

ethinyl estradiol + desogestrelethinyl estradiol + drospirenone
03

Conditions

contraception

Beyond the preview

Go deeper on 2008-005891-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-005891-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call